Chronic Myeloid Leukemia Coverage from Every Angle
Advertisement
Advertisement

Gabriela Hobbs, MD, on the Benefits/Risks of Ponatinib Treatment

Posted: Monday, August 12, 2019

How do you discuss the benefits and risks of ponatinib treatment with patients and families who are considering such therapy?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.